Revamped Wolff New Venture Competition Surprises Audience with Two Medical-Device Champs
The late Thomas John Wolff’56 was an entrepreneur, and UConn School of Business alumnus, who ran five businesses simultaneously. He exemplified values like enthusiasm, mentorship and appreciation. Continue Reading
UConn Today – UConn researchers have developed a device that makes it easier to measure contaminant levels in water. With help from UConn’s National Science Foundation Innovation Corps program, Accelerate UConn, marine geochemist Penny Vlahos and graduate student Joe Warren are now well on their way to commercializing their technology.
UConn Today – When Dr. Courtney Townsel sees an expectant mother with a rare, but serious condition called cervical insufficiency, she only has a few treatment options. Despite steady advances in how we treat mothers and their unborn babies during high-risk pregnancies, none of her options are ideal. In fact, the procedure most commonly performed to treat cervical insufficiency has remained largely the same since the 1950s.
Office of the Vice President for Research -A dozen promising technologies are making progress toward the market thanks to Accelerate UConn (AU), the University of Connecticut’s National Science Foundation (NSF) entrepreneurship program. Several high-potential faculty-student teams recently completed rigorous business training provided through the program, culminating with final presentations before their peers, university administrators, and members of the business community.
LSE Business Review – An ultimate challenge for technology entrepreneurs is the need for capital to continue to innovate, sustain, and commercialise their innovation. The considerable risks associated with the technological feasibility, business model credibility, and product or service viability severely limits access to capital, yet angel investors and venture capitalists fill this need by investing in startups in exchange for an equity stake in the company. Does private equity, in fact, provide value-added services by influencing startup innovation and commercialisation beyond mere capital infusion?
UConn Today – Two UConn researchers have developed a technology that promises big improvements on one of the most common and important emission control tools used to protect the environment: the catalytic converter.
With help from UConn’s NSF program, Accelerate UConn, the pair are now well on their way to commercializing their new technology
UConn Today – Imagine that due to your family medical history, you had an almost 100 percent risk of developing cancer in your lifetime. Now imagine that you discovered this fate before you even started high school. Today that is the reality for many patients with classic familial adenomatous polyposis (FAP), a hereditary colon cancer syndrome.
A team of researchers at UConn Health is exploring ideas for novel approaches to prevent FAP and other inherited colorectal cancer syndromes, and they’re getting out of the lab to do it with help from the University’s new National Science Foundation Innovation Corps Site, Accelerate UConn.
UConn Today – Dry mouth. It’s listed as a possible side effect for hundreds of prescription and non-prescription medications, and can also be brought on by factors such as aging, tobacco use, cancer therapy, or autoimmune diseases such as HIV/AIDS and Sjogren’s Syndrome.
When does it make sense for corporations to expand by adding additional products or businesses to their portfolio?
The topic was the subject of a three-day international conference last month in Strasbourg, France, titled, “Corporate Strategy and Resource Redeployment,” which was organized by UConn Management Professor Timothy B. Folta.Continue Reading